New pill trial aims to halt spread of Tough-to-Treat breast cancer
NCT ID NCT04280536
Summary
This study is testing an oral drug called Lonsurf in people whose breast cancer has spread and worsened despite other treatments. It aims to see if the drug can slow or stop the cancer's growth for a meaningful period. The trial will enroll 86 participants, including those who have and have not received certain prior chemotherapy drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National University Hospital
Singapore, Singapore
Conditions
Explore the condition pages connected to this study.